Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 10-K/A Report 10-K/A
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. 4 Other disposition 10% owner disposed of 850,000 shares (other)
  4. 4 Option exercise Chief Financial Officer acquired 2,500 shares (option exercise)
  5. S-3 Offering Registration Statement
  6. 4 Open-market sale President and CEO sold 14,343 shares at $15.00 ($215,145)
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 8-K Event Results of operations · Regulation FD disclosure
  19. 4 Option exercise Chief Medical Officer acquired 15,117 shares (option exercise)
  20. 8-K Event Other events

Page 33 of 41 · 801 filings